Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-02-04 @ 2:53 AM
Study NCT ID:
NCT07135466
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-22
First Post:
2025-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor in Patients With CD22 B-cell Malignancies
Sponsor:
Sheba Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
Sheba CD22-CAR T cells
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None